-transparent.png){kind=logo}
A double-masked study was performed to investigate a possible side effect of the antiallergic substance Picumast dihydrochloride on lens transparency. 372 patients with Picumast dihydrochloride- or Ketotifen-treatment regularly underwent ophthalmologic examinations and Scheimpflug photography of the anterior eye segment. Results of slitlamp examinations as well as microdensitometric analyzes of the film negatives after one year treatment did not reveal any evidence that Picumast dihydrochloride compromised lens transparency in humans.
Related Publications
O Hockwin, and
U Müller-Breitenkamp, and
H Laser, and
D Messinger, and
G Goder, and
U Meinel
October 1989,
Arzneimittel-Forschung,
O Hockwin, and
U Müller-Breitenkamp, and
H Laser, and
D Messinger, and
G Goder, and
U Meinel
October 1989,
Arzneimittel-Forschung,
O Hockwin, and
U Müller-Breitenkamp, and
H Laser, and
D Messinger, and
G Goder, and
U Meinel
October 1989,
Arzneimittel-Forschung,
O Hockwin, and
U Müller-Breitenkamp, and
H Laser, and
D Messinger, and
G Goder, and
U Meinel
October 1989,
Arzneimittel-Forschung,
O Hockwin, and
U Müller-Breitenkamp, and
H Laser, and
D Messinger, and
G Goder, and
U Meinel
October 1989,
Arzneimittel-Forschung,
O Hockwin, and
U Müller-Breitenkamp, and
H Laser, and
D Messinger, and
G Goder, and
U Meinel
October 1989,
Arzneimittel-Forschung,
O Hockwin, and
U Müller-Breitenkamp, and
H Laser, and
D Messinger, and
G Goder, and
U Meinel
October 1989,
Arzneimittel-Forschung,
O Hockwin, and
U Müller-Breitenkamp, and
H Laser, and
D Messinger, and
G Goder, and
U Meinel
May 2000,
Journal of cataract and refractive surgery,
O Hockwin, and
U Müller-Breitenkamp, and
H Laser, and
D Messinger, and
G Goder, and
U Meinel
October 1989,
Arzneimittel-Forschung,
O Hockwin, and
U Müller-Breitenkamp, and
H Laser, and
D Messinger, and
G Goder, and
U Meinel
January 1991,
Agents and actions. Supplements,
